Tian-Li Wang
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Oncology, Pathology, Molecular BiologyGoogle:
"Tian-Li Wang"Parents
Sign in to add mentor| Peter C. Agre | grad student | 1991-1994 | Johns Hopkins Medical School (Chemistry Tree) | |
| (Co-mentor) | ||||
| Noga Vardi | post-doc | 1996-1998 | Penn (Neurotree) | |
| Bert Vogelstein | post-doc | 2001-2003 | HHMI (Chemistry Tree) | |
Children
Sign in to add trainee| Ren-Chin Wu | grad student | 2012- | Johns Hopkins |
| Kai L. Yap | grad student | 2012 | Northwestern School of Medicine |
Collaborators
Sign in to add collaborator| Peter C. Agre | collaborator | 1991-1994 | Johns Hopkins University of School of Medicine (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Douville C, Lahouel K, Kuo A, et al. (2024) Machine learning to detect the SINEs of cancer. Science Translational Medicine. 16: eadi3883 |
| Mandal J, Yu ZC, Shih IM, et al. (2023) ARID1A loss activates MAPK signaling via DUSP4 downregulation. Journal of Biomedical Science. 30: 94 |
| Kinose Y, Xu H, Kim H, et al. (2023) Dual blockade of BRD4 and ATR/WEE1 pathways exploits loss in clear cell ovarian cancer. Research Square |
| Yu ZC, Li T, Tully E, et al. (2023) Temozolomide sensitizes ARID1A-mutated cancers to PARP inhibitors. Cancer Research |
| Wang Y, Huang P, Wang BG, et al. (2022) Spatial transcriptomic analysis of ovarian cancer precursors reveals reactivation of IGFBP2 during pathogenesis. Cancer Research |
| Mandal J, Mandal P, Wang TL, et al. (2022) Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. Journal of Biomedical Science. 29: 71 |
| Park Y, Jung JG, Yu ZC, et al. (2021) A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation; a Journal of Technical Methods and Pathology. 101: 1505-1512 |
| Park Y, Jung JG, Yu ZC, et al. (2021) A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation; a Journal of Technical Methods and Pathology. 101: 1505-1512 |
| Park Y, Jung JG, Yu ZC, et al. (2021) A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation; a Journal of Technical Methods and Pathology. 101: 1505-1512 |
| Park Y, Jung JG, Yu ZC, et al. (2021) A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation; a Journal of Technical Methods and Pathology. 101: 1505-1512 |